Answer:
Yes, the technology does introduce innovation into the existing production chain. The direct production of monosilane from trialkoxysilane simplifies the conversion pathway and reduces dependence on the conventional chlorosilane route (SiHCl₃ → SiH₄ → polysilicon deposition). This reduces the number of purification stages required to remove chlorine-containing impurities.
The proposed reaction scheme reduces energy consumption during both the preparatory operations and the disproportionation stage. Another key advantage is production flexibility. The resulting monosilane can be used both in the traditional Siemens process and in the more advanced FBR (fluidized bed reactor) process for the deposition of solar-grade silicon, thereby increasing local integration of wafer production and reducing the capital intensity of logistics.
Thus, the innovation does not lie in altering the established processes of ingot growth and wafer slicing, which remain capital-intensive, large-scale industrial stages. Rather, it lies in making the production and supply of the feedstock gas (SiH₄) simpler, safer, and more energy-efficient, thereby making the entire value chain more flexible and resilient.
Answer:
You are correct: silane (SiH₄) is indeed a pyrophoric gas that is prone to spontaneous ignition. Our technology improves control over the monosilane generation process. By reducing the induction period and utilizing suspensions of finely dispersed silicon, the formation of SiH₄ occurs more uniformly, without sharp concentration spikes.
In addition, the integration of monosilane production with solar panel manufacturing reduces the need for transportation and storage of large volumes of silane, which is precisely the primary risk area in conventional production schemes.
This does not eliminate the inherent nature of the risks, but it makes the process more localized and controllable, thereby reducing the likelihood of accidents during storage and transportation.
Answer:
Indeed, the production of high-purity monosilane is a chemically complex process.
The novelty of our technology (EP 2 905 258 B1) lies precisely in the fact that the process is simplified: instead of a multi-stage chlorine-based route, it uses a pathway through trialkoxysilanes, where there are fewer side reactions and fewer contaminating impurities.
Thus, the complexity remains, but it is reduced compared to conventional technologies.
This is one of the main challenges associated with FBR technology.
The patent (our technology) addresses this issue by enabling a more selective and stable SiH₄ generation process, thereby reducing the likelihood of the sudden formation of by-products (particles).
In addition, the patent proposes recirculation and membrane filtration schemes for the suspension, which help control solid residues in the suspension, extend reaction activity, and prevent equipment fouling.
This is indeed a decisive factor.
Our proposed method makes it possible to produce high-purity monosilane with lower levels of unwanted halide impurities, which directly facilitates quality control of the final product. In other words, the technology significantly simplifies the task of achieving the silicon purity required for solar cell production.
Summary:
Effectively addressed within the technology:
Partially addressed:
Answer:
Yes. We strongly welcome independent verification, laboratory analysis, and pilot-scale testing of the technology by potential European partners in order to demonstrate its full industrial applicability and its advantages in accordance with EU standards.
Answer:
The current patent covers the key principles of our technology. At the same time, a significant body of technical knowledge, practical solutions, and production know-how accumulated by the developers is not included in the published patent materials.
Furthermore, the technology has continued to advance since the patent application was filed and the current patent was granted. During this period, the developers have created new technical solutions and improvements that are not covered by the existing patent.
With this in mind, we offer potential partners several complementary forms of cooperation:
If the parties decide to pursue joint patenting, the licensor will be responsible for preparing the materials for the new patent application, developing the required technical documentation, and supporting the application preparation process. The terms of joint ownership of the new patent, allocation of patenting costs, and subsequent use of the developments will be determined by a separate agreement between the parties.
Thus, potential partners are offered not only access to the existing patented technology, but also participation in its further development, industrial implementation, and the creation of a new generation of jointly protected technical solutions.
Answer:
Yes. Within our technology, green hydrogen is one of the by-products of the closed-loop production cycle.
A more detailed description of the technological scheme is available on the “Our Technology” page, as well as in the presentation available for download on our website.
Answer:
Our technology aligns with a number of strategic and environmental priorities of the European Union. The patented process is fundamentally different from the conventional chlorosilane route. It is based on the direct reaction of silicon with ethyl alcohol, while copper(I) chloride (CuCl) is used solely as a catalyst. Chlorine-containing by-products may form only in minor amounts, with their content in the relevant intermediate product not exceeding approximately 1 wt.%. Any such by-products are removed during purification. The technology enables the integration of monosilane and solar panel production within a single complex, reducing logistical risks and emissions.
In addition, the technology supports the development of an independent European solar supply chain, which directly aligns with EU objectives aimed at reducing dependence on external suppliers, including China, and strengthening strategic autonomy.
Answer:
Yes. Our technology is modular and scalable, allowing monosilane production to be deployed both at large industrial facilities and at the level of medium-sized and small enterprises. This creates new opportunities for Europe to localize photovoltaic manufacturing and enhance the resilience of regional supply chains.
Answer:
Yes. For the first time, our technology offers Europe an integrated manufacturing model that brings monosilane and solar panel production together within a single industrial complex. Producing monosilane close to where it is used reduces logistics costs and the risks associated with transporting and storing this pyrophoric gas, while strengthening the resilience and technological autonomy of Europe’s photovoltaic industry.
Answer:
Yes. While the solar energy sector remains our primary focus, the technology can also be applied in industries where high-purity monosilane is used, including microelectronics and semiconductors, integrated circuits and microchips, thin-film coatings, and the chemical and silicone industries. This is also consistent with the objectives of the EU Chips Act.
Answer:
Yes. The patented technology is designed for the continuous production of high-purity monosilane and provides for additional purification of the final gas. The patent explicitly states that the resulting monosilane can be used to form semiconductor thin films.
The scalable process architecture makes it possible to establish local monosilane production in the immediate vicinity of a semiconductor manufacturing site. This approach reduces the costs and risks associated with transporting pyrophoric gas over long distances and storing it for extended periods, while providing the facility with a stable local supply of high-purity monosilane.
Answer:
Our technology received support and partial co-financing from OCI (South Korea), one of the world's leading producers of monosilane and polysilicon. Thanks to their investment and legal support, patent protection was obtained in Europe, the United States, Japan, the Republic of Korea, and Taiwan, while a corresponding patent application was published in China.
Answer:
The technology has been under continuous development since 2010 and continues to be refined.
Answer:
The European patent EP 2905258 B1 was granted in 2022.
The patent is jointly owned by OCI Company Ltd. and the Arifov Institute of Ion-Plasma and Laser Technologies of the Uzbekistan Academy of Sciences.
Under the Technology License and Fee Agreement, the Arifov Institute of Ion-Plasma and Laser Technologies has the exclusive right to grant licenses to third parties for the commercial production of monosilane using the Technology and its own Improvements in Europe and the independent states and countries of the former USSR.
Answer:
The monosilane production technology was developed by the Laboratory of Applied Nanotechnologies of the Institute of Ion-Plasma and Laser Technologies named after U. Arifov of the Academy of Sciences of the Republic of Uzbekistan.
International representation of the technology and negotiations with potential partners, investors, and industrial organizations are conducted on the basis of an official authorization issued by the Institute in the name of Dr. Anvar Nazirov.
The authorization grants the right to represent the technology and to conduct negotiations regarding international cooperation, licensing, industrial evaluation, and commercialization of the technology.
To review the Institute’s official authorization, please download the document below:
Dr. Anvar Nazirov is the authorized representative of the project for international cooperation, licensing, and engagement with foreign partners. He is a researcher and expert on the economics and politics of Central Asia with many years of experience in international analytical activities.
LinkedIn: Anvar Nazirov
Facebook: Anvar Nazirov
Answer:
The technology presentation is available for download via the link provided at the bottom of each page of our website.
Answer:
At present, the technology is protected by granted patents in Europe, the United States, Japan, the Republic of Korea, and Taiwan. A corresponding patent application has also been published in China.
Please download our presentation:
Download Presentation